AR228256A1 - Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno - Google Patents

Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno

Info

Publication number
AR228256A1
AR228256A1 AR281109A AR28110980A AR228256A1 AR 228256 A1 AR228256 A1 AR 228256A1 AR 281109 A AR281109 A AR 281109A AR 28110980 A AR28110980 A AR 28110980A AR 228256 A1 AR228256 A1 AR 228256A1
Authority
AR
Argentina
Prior art keywords
pirimidinilamino
cicloalqueno
diaza
elaboration
procedure
Prior art date
Application number
AR281109A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AR228256A1 publication Critical patent/AR228256A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
AR281109A 1979-05-18 1980-05-19 Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno AR228256A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH466979 1979-05-18

Publications (1)

Publication Number Publication Date
AR228256A1 true AR228256A1 (es) 1983-02-15

Family

ID=4280399

Family Applications (1)

Application Number Title Priority Date Filing Date
AR281109A AR228256A1 (es) 1979-05-18 1980-05-19 Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno

Country Status (21)

Country Link
EP (1) EP0019811A1 (es)
JP (1) JPS55154971A (es)
KR (1) KR830002757A (es)
AR (1) AR228256A1 (es)
AU (1) AU5848480A (es)
DD (1) DD150609A5 (es)
DK (1) DK214480A (es)
ES (1) ES8104279A1 (es)
FI (1) FI801600A (es)
GB (1) GB2052487B (es)
GR (1) GR68453B (es)
IE (1) IE49803B1 (es)
IL (1) IL60086A (es)
MA (1) MA18829A1 (es)
NO (1) NO801469L (es)
NZ (1) NZ193730A (es)
OA (1) OA06533A (es)
PL (1) PL224313A1 (es)
PT (1) PT71251A (es)
ZA (1) ZA802909B (es)
ZW (1) ZW11880A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507146A (en) * 1982-12-28 1985-03-26 Ciba-Geigy Corporation 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity
DE3829469A1 (de) * 1988-08-31 1990-03-01 Bayer Ag Verfahren zur herstellung von substituierten n-azinyl-n'-sulfonyl-isothioharnstoffen und n-azinyl-iminodithiokohlensaeure-s,s-diester als zwischenprodukte zu ihrer herstellung
CA2269971A1 (en) * 1997-09-03 1999-03-11 Trent Lee Abraham Pyrimidine derivatives
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
JP4922539B2 (ja) 2000-09-15 2012-04-25 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼインヒビターとして有用なピラゾール化合物
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
NZ526470A (en) 2000-12-21 2006-03-31 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors
SK9562003A3 (en) * 2001-01-31 2004-04-06 Synaptic Pharma Corp Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
EP1483247B1 (en) 2002-03-13 2009-06-24 Euro-Celtique S.A. Aryl substituted pyrimidines and the use thereof
WO2003078427A1 (en) 2002-03-15 2003-09-25 Vertex Pharmaceuticals, Inc. Azolylaminoazines as inhibitors of protein kinases
JP2005520821A (ja) * 2002-03-15 2005-07-14 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド 4−アミノピリミジン及び表面の抗菌処理のためのその使用
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
AU2003257078B2 (en) 2002-08-02 2010-04-01 Vertex Pharmaceuticals Incorporated Pyrazole compositions useful as inhibitors of GSK-3
WO2004072029A2 (en) 2003-02-06 2004-08-26 Vertex Pharmaceuticals Incorporated Pyrazolopyridazines useful as inhibitors of protein kinases
WO2007022384A2 (en) 2005-08-18 2007-02-22 Vertex Pharmaceuticals Incorporated Pyrazine kinase inhibitors
EP1951715B1 (en) 2005-11-03 2013-09-04 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
ATE457311T1 (de) 2006-11-02 2010-02-15 Vertex Pharma Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
EP2099787B1 (en) 2006-12-19 2010-07-21 Vertex Pharmaceuticals, Inc. Aminopyrimidines useful as inhibitors of protein kinases
KR20090120510A (ko) 2007-03-09 2009-11-24 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로서 유용한 아미노피리미딘
CA2679701A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyridines useful as inhibitors of protein kinases
NZ579446A (en) 2007-03-09 2012-02-24 Vertex Pharma Aminopyrimidines useful as inhibitors of protein kinases
AU2008240313A1 (en) 2007-04-13 2008-10-23 Aj Park Aminopyrimidines useful as kinase inhibitors
CN101801959A (zh) 2007-05-02 2010-08-11 沃泰克斯药物股份有限公司 可用作激酶抑制剂的氨基嘧啶类化合物
EP2152694A2 (en) 2007-05-02 2010-02-17 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
AU2008282156B2 (en) 2007-07-31 2014-07-17 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
EP2323622A1 (en) 2008-09-03 2011-05-25 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same
PL2364314T3 (pl) * 2008-12-09 2014-08-29 Gilead Sciences Inc Modulatory receptorów Toll-podobnych
KR102328682B1 (ko) * 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines

Also Published As

Publication number Publication date
ES491514A0 (es) 1981-04-16
FI801600A (fi) 1980-11-19
DK214480A (da) 1980-11-19
OA06533A (fr) 1981-07-31
KR830002757A (ko) 1983-05-30
GB2052487B (en) 1983-05-11
NO801469L (no) 1980-11-19
DD150609A5 (de) 1981-09-09
PL224313A1 (es) 1981-02-13
GB2052487A (en) 1981-01-28
IL60086A0 (en) 1980-07-31
ES8104279A1 (es) 1981-04-16
EP0019811A1 (de) 1980-12-10
JPS55154971A (en) 1980-12-02
IE801023L (en) 1980-11-18
AU5848480A (en) 1980-11-20
IL60086A (en) 1984-03-30
PT71251A (en) 1980-06-01
IE49803B1 (en) 1985-12-25
GR68453B (es) 1981-12-30
ZA802909B (en) 1981-05-27
ZW11880A1 (en) 1980-12-17
NZ193730A (en) 1982-12-21
MA18829A1 (fr) 1980-12-31

Similar Documents

Publication Publication Date Title
AR228256A1 (es) Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno
ES514585A0 (es) Procedimiento para la obtencion de derivados de oxazol trisustituidos.
AR224008A1 (es) Procedimiento para preparar polihidro-3,7-dimetil-8-(2-(tetrahidro-4-hidroxi-6-oxo-2h-piran-2-il)-etil)-1-naftil-2-metilbutirato
ES535946A0 (es) Procedimiento para preparar 2-(2-benzoil sustituido)-1, 3-ciclohexanodionas
ES488196A0 (es) Procedimiento para la preparacion de compuestos de dioxacinabasicos
AR230437A1 (es) Procedimiento para la fabricacion de derivados de 2-(dialquamino,pirrolidinil o piperidinil)-alquil-tio-quinolina
AR227527A1 (es) Procedimiento para la elaboracion de nuevos compuestos n-oxaciclilalquil-piperidil-diazoicos
ES497366A0 (es) Un procedimiento para la preparacion de nuevos compuestos de mercaptoorganosiloxano.
ES493846A0 (es) Un procedimiento para la preparacion de nuevos compuestos oligolipidos.
ES491341A0 (es) Procedimiento para la obtencion de derivados fluorados de triazolil-butano, de efecto fungicida
AR227286A1 (es) Procedimiento para la elaboracion de nuevos compuestos de 1-(2-imidazolidin-1-ilo-alquil)-3-fenilurea o tiourea
ES489689A0 (es) Procedimiento para preparar compuestos de isotiourea
MX6580E (es) Procedimiento para la preparacion de compuestos acetoximetil-penam
ES493499A0 (es) Procedimiento para preparar compuestos de 3-metilemazetidina
AR224318A1 (es) Procedimiento para la preparacion de compuestos de piran-4-ona
AR213659A1 (es) Procedimiento para la preparacion de 2-(4-(aroil o heteroaroil)-piperazin-1-il)-4-amino-6,7-dimetoxiquinazolinas
ES488709A0 (es) Procedimiento para la preparacion de compuestos diorganomag-nesicos,r2mg
AR223319A1 (es) Procedimiento para la elaboracion de compuestos de 6-amino-penam
ES493016A0 (es) Procedimiento para la preparacion de nuevas 2-(perhi- dro-1,4-diazino)-pirimido(5,4-d)pirimidinas
ES494211A0 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
AR229174A1 (es) Procedimiento para la preparacion de nuevas 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas
AR216675A1 (es) Procedimiento para la preparacion de 2-(gamma-(1-piperidinil)propil)-1,2-benzisotiazol-3-ona
ES496509A0 (es) Procedimiento para la preparacion de nuevos compuestos ca- tionicos
MX5101E (es) Procedimiento para la preparacion de 2-(2',2',2',-trihalogenoetil)-4-halogenociclobutan-1-onas
ES497784A0 (es) Procedimiento para la preparacion de compuestos de guanidinio.